Pyrotinib-based treatments in HER2-positive breast cancer patients with brain metastases
Authors:
Open Access
- 4 November 2022
- journal article
- research article
- Published by Taylor & Francis in Annals of Medicine
- Vol. 54 (1) , 3084-3094
Abstract
Extensive application of anti-HER2 targeted therapy improves significantly the HER2-positive advanced breast cancer (BC) prognosis, however, it is still difficult to treat brain metastasis. In curr...Keywords
Funding Information
- Youth Scientific and Technological Innovation Talents Training Project of Xinjiang Uyghur autonomous region (QN2016YX0274)
This publication has 46 references indexed in Scilit:
- nab-Paclitaxel dose and schedule in breast cancerBreast Cancer Research, 2015
- Efficacy of nab-paclitaxel plus trastuzumab in a long-surviving heavily pretreated HER2-positive breast cancer patient with brain metastasesOncoTargets and Therapy, 2015
- Capecitabine and lapatinib uptake in surgically resected brain metastases from metastatic breast cancer patients: a prospective studyNeuro-Oncology, 2014
- nab-Paclitaxel in combination with biologically targeted agents for early and metastatic breast cancerCancer Treatment Reviews, 2014
- A phase II, randomized, multicenter study evaluating the combination of lapatinib and vinorelbine in women with ErbB2 overexpressing metastatic breast cancerBreast Cancer Research and Treatment, 2014
- CNS Metastases in Breast Cancer: Old Challenge, New FrontiersClinical Cancer Research, 2013
- Incidence and risk of central nervous system metastases as site of first recurrence in patients with HER2-positive breast cancer treated with adjuvant trastuzumabAnnals of Oncology, 2013
- A Phase II Study of Weekly Nanoparticle Albumin-Bound Paclitaxel With or Without Trastuzumab in Metastatic Breast CancerClinical Breast Cancer, 2011
- Phase III Randomized Study Comparing Docetaxel Plus Trastuzumab With Vinorelbine Plus Trastuzumab As First-Line Therapy of Metastatic or Locally Advanced Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer: The HERNATA StudyJournal of Clinical Oncology, 2011
- Phase III Trial of Nanoparticle Albumin-Bound Paclitaxel Compared With Polyethylated Castor Oil–Based Paclitaxel in Women With Breast CancerJournal of Clinical Oncology, 2005